Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DCL000570

Drug Information
NameMK-2206
CompanyMerck
IndicationColon Cancer; Rectal Cancer
[ICD9: 140-229, 153, 154   ICD10: C00-C96, C18-C21, C20]
Phase II    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C25H21N5O.2ClH/c26-25(12-4-13-25)18-9-7-17(8-10-18)22-19(16-5-
2-1-3-6-16)15-20-21(27-22)11-14-30-23(20)28-29-24(30)31;;/h1-3,5-
11,14-15H,4,12-13,26H2,(H,29,31);2*1H
InChIKeyHWUHTJIKQZZBRA-UHFFFAOYSA-N
Canonical SMILESC1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N.Cl.Cl    
PubChem Compound IDCID 46930998.
ClinicalTrials.govNCT01186705;
TargetRAC-alpha serine/threonine-protein kinaseInhibitor[1][2]
Ref 1Merck. Product Development Pipeline. July 15 2009. To Reference
Ref 2Merck. Report of Merck. June 04 2009. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543